Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2744726rdf:typepubmed:Citationlld:pubmed
pubmed-article:2744726lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2744726lifeskim:mentionsumls-concept:C0001554lld:lifeskim
pubmed-article:2744726lifeskim:mentionsumls-concept:C0039005lld:lifeskim
pubmed-article:2744726lifeskim:mentionsumls-concept:C0680730lld:lifeskim
pubmed-article:2744726lifeskim:mentionsumls-concept:C0021665lld:lifeskim
pubmed-article:2744726lifeskim:mentionsumls-concept:C0175630lld:lifeskim
pubmed-article:2744726lifeskim:mentionsumls-concept:C1979963lld:lifeskim
pubmed-article:2744726lifeskim:mentionsumls-concept:C2003903lld:lifeskim
pubmed-article:2744726lifeskim:mentionsumls-concept:C1148554lld:lifeskim
pubmed-article:2744726pubmed:issue3lld:pubmed
pubmed-article:2744726pubmed:dateCreated1989-8-17lld:pubmed
pubmed-article:2744726pubmed:abstractTextRecombinant human insulin-like growth factor I (IGF-I) was injected daily (4 or 8 mg/pig) as an intra-arterial bolus into pigs for 3 consecutive days and the serum IGF-I concentration was measured to determine disappearance profiles. IGF-I partitioned to a fast component (half-life, t 1/2 = 5.7 min) and a slow component (t 1/2 = 253 min) in pig serum. Chromatography of serum revealed that the fast component comprised unbound IGF-I, whereas the slow component comprised IGF-I bound to 40- and 150-kD serum IGF-binding proteins. In addition, administration of exogenous IGF-I caused significant hypoglycemia.lld:pubmed
pubmed-article:2744726pubmed:languageenglld:pubmed
pubmed-article:2744726pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2744726pubmed:citationSubsetIMlld:pubmed
pubmed-article:2744726pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2744726pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2744726pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2744726pubmed:statusMEDLINElld:pubmed
pubmed-article:2744726pubmed:issn0301-0163lld:pubmed
pubmed-article:2744726pubmed:authorpubmed-author:BurleighB DBDlld:pubmed
pubmed-article:2744726pubmed:authorpubmed-author:EthertonT DTDlld:pubmed
pubmed-article:2744726pubmed:authorpubmed-author:GopinathRRlld:pubmed
pubmed-article:2744726pubmed:authorpubmed-author:WaltonP EPElld:pubmed
pubmed-article:2744726pubmed:issnTypePrintlld:pubmed
pubmed-article:2744726pubmed:volume31lld:pubmed
pubmed-article:2744726pubmed:ownerNLMlld:pubmed
pubmed-article:2744726pubmed:authorsCompleteYlld:pubmed
pubmed-article:2744726pubmed:pagination138-42lld:pubmed
pubmed-article:2744726pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:2744726pubmed:meshHeadingpubmed-meshheading:2744726-...lld:pubmed
pubmed-article:2744726pubmed:meshHeadingpubmed-meshheading:2744726-...lld:pubmed
pubmed-article:2744726pubmed:meshHeadingpubmed-meshheading:2744726-...lld:pubmed
pubmed-article:2744726pubmed:meshHeadingpubmed-meshheading:2744726-...lld:pubmed
pubmed-article:2744726pubmed:meshHeadingpubmed-meshheading:2744726-...lld:pubmed
pubmed-article:2744726pubmed:meshHeadingpubmed-meshheading:2744726-...lld:pubmed
pubmed-article:2744726pubmed:meshHeadingpubmed-meshheading:2744726-...lld:pubmed
pubmed-article:2744726pubmed:meshHeadingpubmed-meshheading:2744726-...lld:pubmed
pubmed-article:2744726pubmed:meshHeadingpubmed-meshheading:2744726-...lld:pubmed
pubmed-article:2744726pubmed:year1989lld:pubmed
pubmed-article:2744726pubmed:articleTitleAdministration of recombinant human insulin-like growth factor I to pigs: determination of circulating half-lives and chromatographic profiles.lld:pubmed
pubmed-article:2744726pubmed:affiliationDepartment of Dairy and Animal Science, Pennsylvania State University, University Park.lld:pubmed
pubmed-article:2744726pubmed:publicationTypeJournal Articlelld:pubmed